Drug
rigosertib sodium
rigosertib sodium is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
25%
Ph phase_1
2
50%
Ph phase_3
1
25%
Phase Distribution
3
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (25.0%)
Phase 12 (50.0%)
Phase 31 (25.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedearly_phase_1
Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC
NCT04177498
completedphase_3
Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine
NCT01928537
completedphase_1
Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer
NCT01538563
completedphase_1
Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer
NCT01538537
Clinical Trials (4)
Showing 4 of 4 trials
NCT04177498Early Phase 1
Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC
NCT01928537Phase 3
Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine
NCT01538563Phase 1
Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer
NCT01538537Phase 1
Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4